D530-0465 Screening compound: 2-[5,7-bis(4-methylphenyl)-4H,7H-[1,2,3,4]tetrazolo[1,5-a]pyrimidin-4-yl]-N-(4-hydroxyphenyl)acetamide

D530-0465 Screening compound: 2-[5,7-bis(4-methylphenyl)-4H,7H-[1,2,3,4]tetrazolo[1,5-a]pyrimidin-4-yl]-N-(4-hydroxyphenyl)acetamide
D530-0465 Screening compound: 2-[5,7-bis(4-methylphenyl)-4H,7H-[1,2,3,4]tetrazolo[1,5-a]pyrimidin-4-yl]-N-(4-hydroxyphenyl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound D530-0465
2-[5,7-bis(4-methylphenyl)-4H,7H-[1,2,3,4]tetrazolo[1,5-a]pyrimidin-4-yl]-N-(4-hydroxyphenyl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D530-0465

Molecular Formula

C26H24N6O2 (C26 H24 N6 O2)

Compound Name

2-[5,7-bis(4-methylphenyl)-4H,7H-[1,2,3,4]tetrazolo[1,5-a]pyrimidin-4-yl]-N-(4-hydroxyphenyl)acetamide

IUPAC name

2-[57-bis(4-methylphenyl)-4H7H-[1234]tetrazolo[15-a]pyrimidin-4-yl]-N-(4-hydroxyphenyl)acetamide

SMILES

Cc1ccc(C2n3nnnc3N(CC(Nc(cc3)ccc3O)=O)C(c3ccc(C)cc3)=C2)cc1

InChI

InChI=1S/C26H24N6O2/c1-17-3-7-19(8-4-17)23-15-24(20-9-5-18(2)6-10-20)32-26(28-29-30-32)31(23)16-25(34)27-21-11-13-22(33)14-12-21/h3-15,24,33H,16H2,1-2H3,(H,27,34)/t24-/m1/s1

InChI Key

UWUFJANEMKMOSZ-XMMPIXPASA-N

MDL Number (MFCD)

MFCD27591564

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

452.52

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.870

Distribution Coefficient, logD

4.869

Water Solubility, LogSw

-4.35

Polar Surface Area

81.363

Acid Dissociation Constant (pKa)

10.11

Base Dissociation Constant (pKb)

1.88

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

15.40

D530-0465 in Drug Discovery

Included in Screening Libraries

Hsp90-Targeted Library (11355 compounds)

Protein-Protein Interaction Library (218420 compounds)

Covalent Inhibitors Library (7986 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
Mechanism of action:
  • PPI modulators
Structure:
  • Cyclic compounds
  • 3D
  • Fragments

References: we are preparing a list of scientific research reports with D530-0465 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D530-0465?
Check Price and Availability of D530-0465, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D530-0465 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D530-0465
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D530-0465
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D530-0465 available by request